Much like the lung-condition game Alvio we profiled here last year, which encouraged and challenged kids to continue their conditioning by playing app-based games on their smartphones and tablets through a custom spirometer accessory, Knox's Spiritus system is helping parents and patients personally monitor their lung capacity and track pulmonary performance and progress.
The tool will particularly help pediatric patients, many of whom have trouble tracking their programs.
Having originated in a lab at UCSF, and with a core founding team made up of individuals who've battled asthma personally, Spiritus is attracting the right sort of attention, with press and recognition coming from Inc. magazine, the Global Fab Awards and the Kairos Society. The hope is that, once the spirometer is able to be mass produced, that the tool could cost about $100 in comparison to thousands of dollars for a standard desktop spirometer.
Approximately 1 in 12 people in the US (about 25 million people) currently suffer from some form of asthma.